Necrotizing Enterocolitis

  1. Overview — What Is NEC?
  2. Risk Factors
  3. Signs and Symptoms
  4. Diagnosis: Bell's Staging Criteria
  5. Medical Management
  6. Surgical Management
  7. Prevention
  8. Long-Term Outcomes for Families
  9. Key Research Papers
  10. Connections
  11. Featured Videos

Overview — What Is NEC?

Necrotizing enterocolitis (NEC) is the most devastating gastrointestinal emergency of prematurity. The disease causes portions of the intestine to become inflamed, injured, and in severe cases to die — a process called transmural necrosis — which can progress to perforation of the bowel wall, spillage of intestinal contents into the abdomen (peritonitis), and overwhelming sepsis. For families in the NICU, receiving a NEC diagnosis is one of the most frightening moments imaginable. Understanding what is happening inside your baby's body, and why, can help you ask better questions and be a more effective partner in your infant's care.

NEC occurs in approximately 1–3 per 1,000 live births overall, but rates climb steeply with decreasing gestational age and birth weight. Among very low birth weight (VLBW) infants — those weighing less than 1,500 grams — about 7% will develop NEC. The overall mortality rate is 15–30%, and in infants who require surgery the death rate reaches 40–50%. NEC is one of the leading causes of death from gastrointestinal disease in newborns worldwide.

The biology of NEC centers on three interacting vulnerabilities unique to premature infants:

  1. Immature gut mucosa — the lining of the premature intestine has weaker barrier function and a less mature immune system than a term baby's gut, making it easier for bacteria to invade the bowel wall.
  2. Abnormal bacterial colonization — instead of the gradual, healthy colonization that happens in a term baby born vaginally, premature infants in the NICU are colonized by hospital bacteria (often gram-negative organisms) that trigger an exaggerated inflammatory response in the fragile intestinal wall.
  3. Ischemia-reperfusion injury — reduced blood flow to the gut (ischemia), followed by the return of blood flow (reperfusion), generates a burst of toxic free radicals that injure the intestinal lining. Many of the conditions that affect premature infants — low blood pressure, patent ductus arteriosus, polycythemia — impair gut blood flow.

These three factors conspire to trigger a cascade of inflammation that, if unchecked, destroys the full thickness of the intestinal wall. NEC most commonly strikes the terminal ileum and right colon, though any portion of the bowel can be involved. Peak onset is typically 2–4 weeks after birth, and the risk is inversely proportional to gestational age: a 23–24 week infant has a dramatically higher risk than a 32-weeker, reflecting the degree of intestinal immaturity.

Back to Table of Contents

Risk Factors

NEC is predominantly a disease of premature infants, and most risk factors either reflect or compound the fundamental vulnerability of immaturity.

Prematurity and Low Birth Weight

Prematurity is the single greatest risk factor for NEC. More than 90% of NEC cases occur in premature infants, and gestational age at birth is the strongest predictor of who will develop the disease. Infants born at 23–27 weeks gestation carry the highest absolute risk. Among VLBW infants (<1,500 g), the incidence is approximately 7%; among extremely low birth weight infants (<1,000 g), rates can exceed 10–12% in some NICU cohorts.

Formula Feeding

The type of milk a premature infant receives has a profound effect on NEC risk. Human breast milk — from the infant's own mother or from a donor milk bank — dramatically reduces the risk of NEC compared to infant formula. Studies in VLBW infants show a 3 to 4-fold higher NEC rate with formula feeding. The 1990 observational study by Lucas and Cole (PMID 1978356) was among the first to establish this clearly. Breast milk contains lactoferrin, secretory IgA, growth factors, oligosaccharides that feed beneficial bacteria, and immune cells — a biological package that formula cannot replicate. Even small volumes of colostrum in the first days of life provide meaningful protection.

Intrauterine Growth Restriction (IUGR)

Infants who were growth-restricted in the womb — often due to placental insufficiency — have chronic gut ischemia before birth. This pre-existing injury primes the intestine for NEC after delivery, independent of gestational age. IUGR infants with absent or reversed end-diastolic flow on prenatal Doppler studies are at particularly high risk.

Congenital Heart Disease

Infants with congenital heart disease (CHD), especially those with a patent ductus arteriosus (PDA) causing diastolic steal from the gut vasculature, or those with systemic hypotension from structural defects, have impaired mesenteric blood flow. Left-sided obstructive lesions (hypoplastic left heart syndrome, coarctation) carry especially high NEC risk.

Transfusion-Associated NEC (TANEC)

A controversial but clinically recognized association exists between red blood cell (RBC) transfusions and NEC onset in the following 48–72 hours. This phenomenon — called transfusion-associated NEC or TANEC — has been observed in multiple retrospective studies (Sharma et al., PMID 16899787). The mechanism is debated; proposed explanations include RBC-mediated nitric oxide scavenging causing gut ischemia, storage lesion effects, or priming of the inflammatory cascade. Some NICUs hold enteral feeds around transfusions as a precaution, though evidence that this prevents TANEC is not conclusive.

Polycythemia

Elevated red blood cell mass (hematocrit >65%) increases blood viscosity and can impair microvascular flow in the mesenteric circulation, predisposing to gut ischemia.

Antibiotic Exposure and Microbiome Disruption

Prolonged empiric antibiotic courses in the NICU alter the developing gut microbiome in ways that may increase NEC risk. Early colonization with beneficial organisms (particularly Bifidobacterium species) appears protective, and antibiotics that suppress these organisms may remove a key barrier to NEC-triggering pathogen overgrowth.

Back to Table of Contents

Signs and Symptoms

NEC typically develops over hours to days. The NICU team watches for a combination of local intestinal signs and systemic signs of illness. As a parent, you do not need to memorize all of these — your baby's nurses and doctors are monitoring continuously — but knowing what the team is watching for helps you understand why they sometimes change your baby's care plan quickly and without much warning.

Early Warning Signs

Signs of Advanced NEC

When to Call Your NICU Nurse Immediately

If you are at your baby's bedside and notice any of the following, call your nurse right away — do not wait:

You know your baby. NICU nurses and parents are partners — your observations matter.

Back to Table of Contents

Diagnosis: Bell's Staging Criteria

NEC is diagnosed using a combination of clinical signs, blood tests, and imaging. The Bell's Staging Criteria, originally described in 1978 and modified over subsequent decades, provide a standardized framework for describing the severity of NEC. Gephart et al. (PMID 22739563) reviewed the evidence base for Bell staging and its continued clinical utility.

Stage I — Suspected NEC

The baby has non-specific signs that could represent many conditions: temperature instability, apnea, feeding intolerance, mild abdominal distension. Abdominal X-rays may be normal or show mild, non-specific abnormalities such as dilated bowel loops. At this stage, the team may begin NEC precautions (holding feeds, monitoring closely) while further evaluation proceeds.

Stage II — Confirmed NEC

The hallmark of Stage II is pneumatosis intestinalis — gas trapped within the wall of the bowel, visible on abdominal X-ray as small bubbles or a bubbly/frothy pattern along the bowel wall. This finding is pathognomonic for NEC: it means bacteria have invaded the intestinal wall and are producing gas as they proliferate. Another important Stage II finding is portal venous gas — gas that has entered the portal venous system and tracks to the liver, visible as branching lucency overlying the liver on X-ray or ultrasound. At Stage II, NEC is confirmed and treatment begins in earnest.

Stage III — Advanced NEC

Stage III represents full-thickness bowel necrosis with or without perforation. The radiographic key sign is pneumoperitoneum — free air visible under the diaphragm or in the flanks on X-ray, indicating the bowel has perforated and air has escaped into the abdominal cavity. Clinically, Stage III infants are critically ill: cardiovascular collapse, DIC, and multi-organ dysfunction are common. Surgical intervention is almost always required at Stage III.

Imaging Studies

Laboratory Findings

No single blood test diagnoses NEC, but the team monitors: complete blood count (CBC) for thrombocytopenia and neutropenia; C-reactive protein (CRP) as an inflammation marker; blood gas for metabolic acidosis; blood culture (positive in 20–30% of NEC cases); and coagulation studies for DIC.

Back to Table of Contents

Medical Management (Stage I–II)

When NEC is suspected or confirmed at Stage I or II, the treatment strategy is to rest the bowel completely while supporting the infant with intravenous nutrition and antibiotics, and to monitor intensively for any sign of deterioration requiring surgery.

Bowel Rest (NPO)

All feedings — including breast milk — are stopped immediately. The bowel needs to be completely empty and rested. A nasogastric (NG) tube is placed to decompress the stomach, draining away swallowed air and gastric secretions that would otherwise put pressure on the injured intestine. Bowel rest typically lasts 7–14 days, though the exact duration depends on the infant's clinical course and imaging findings.

Intravenous Nutrition (TPN)

Since the baby cannot eat, all nutrition is delivered through a central venous line as total parenteral nutrition (TPN) — a carefully formulated solution containing glucose, amino acids, lipids, electrolytes, vitamins, and minerals. TPN can sustain premature infants for weeks and is a critical bridge during bowel rest.

Intravenous Antibiotics

NEC involves bacterial invasion of the bowel wall, so broad-spectrum IV antibiotics are a cornerstone of treatment. Common regimens include:

Antibiotic courses typically run 7–14 days in confirmed NEC.

Serial Monitoring

During the medical management phase, the team performs serial abdominal examinations and abdominal X-rays every 6–8 hours to detect any sign of deterioration. Blood pressure, urine output, blood gases, and platelet counts are monitored continuously. The team is watching for the threshold signs that indicate medical management is failing and surgery is needed.

Supportive Care

Back to Table of Contents

Surgical Management (Stage III / Perforation)

When NEC progresses beyond what medical management can control, surgery becomes necessary. This is one of the most difficult conversations NICU families will ever have. Your surgical team will explain the specific plan for your baby; the information below provides context for that conversation.

Surgical Indications

Surgical Options

Two main approaches are used, and the choice depends primarily on the infant's size, gestational age, and overall stability:

Short Bowel Syndrome

When extensive lengths of bowel must be removed, the remaining intestine may not be able to absorb enough nutrition for normal growth — a condition called short bowel syndrome (SBS). The risk is highest when more than 50% of the small bowel is lost, particularly if the ileocecal valve is also removed. Children with SBS may require long-term or lifelong parenteral nutrition (IV feeding) and face a long road of intestinal rehabilitation or, in severe cases, intestinal transplantation. Rees et al. (PMID 17218381) published important long-term outcome data for surgical NEC survivors.

Back to Table of Contents

Prevention

Given the devastating consequences of NEC, preventing it is a major focus of neonatal medicine. Several interventions have strong evidence and are now standard of care in many NICUs worldwide.

Human Breast Milk — The Single Most Important Prevention

This bears repeating because the evidence is so strong and the implication so practical: human breast milk reduces the risk of NEC by 3 to 4 times in VLBW infants compared to formula. The landmark 1990 study by Lucas and Cole (PMID 1978356) followed 926 preterm infants and found that formula feeding was associated with a 6–10 fold increase in NEC risk. Even small volumes of your own colostrum in the first days after your baby is born are protective. Oropharyngeal colostrum (swabbing the inside of the baby's cheek with expressed colostrum before they can tolerate enteral feeds) is practiced in many NICUs for this reason.

When a mother's own milk is not available, pasteurized donor human milk (DHM) from a milk bank is the next best option. The Cochrane review by Quigley and McGuire (PMID 25199919) confirmed that compared to formula, DHM significantly reduces the risk of NEC — though the protection may be somewhat less than with a mother's own milk. Many NICUs now have access to donor milk banks, and families should ask about this if their own milk supply is limited.

Probiotics

Multiple randomized controlled trials and meta-analyses have found that supplementing premature infants with probiotic bacteria — particularly Lactobacillus and Bifidobacterium species — reduces the incidence of NEC. The Cochrane review by Alfaleh et al. (PMID 22161407) analyzed 16 trials and concluded that enteral probiotic supplementation significantly reduces the risk of severe NEC (Stage II or higher) and all-cause mortality in preterm infants. On the basis of this evidence, many neonatal units in the UK, Australia, and elsewhere now routinely offer probiotics to VLBW infants. Adoption in North America has been more cautious due to concerns about product quality and regulatory oversight of probiotic preparations, but practice is evolving.

Antenatal Corticosteroids

Betamethasone or dexamethasone given to mothers at risk of preterm delivery before 34 weeks accelerates fetal gut maturation, among other organ-maturing effects. Antenatal steroids reduce the overall severity of prematurity complications and are associated with lower NEC rates.

Standardized Feeding Protocols

NICUs that use standardized, conservative enteral feeding advancement protocols — specifying how quickly milk volumes are increased, minimum intervals between feeds, and criteria for feed interruption — have lower NEC rates than units without such protocols. Key principles include slow advancement (typically 15–25 mL/kg/day), avoidance of hyperosmolar feeds and medications, and careful monitoring for feeding intolerance at every step.

Caffeine

Caffeine citrate, widely used in VLBW infants to treat and prevent apnea of prematurity, has been associated with lower NEC rates in several studies, including the large CAP trial. The mechanism may relate to improved intestinal blood flow and reduced gut ischemia. Caffeine is now almost universally used in VLBW infants, providing an incidental NEC-preventive benefit.

Judicious Transfusion Practices

Given the controversy around TANEC, some NICUs hold or reduce enteral feeds in the period surrounding red blood cell transfusions. Whether this practice prevents NEC is not established, but it remains common out of caution.

Back to Table of Contents

Long-Term Outcomes for Families

If your baby has had NEC, you are living through one of the most frightening experiences a NICU family can face. It is important to know both the full picture of long-term challenges and the genuine grounds for hope. Many NEC survivors go on to live full, productive lives — but some face ongoing medical complexity that requires sustained family commitment and professional support.

Survival and Medical NEC

Most infants with Stage I or II NEC who respond to medical management recover without surgery and have good long-term GI outcomes. Strictures — narrowings of the intestine at sites of prior NEC inflammation — can develop weeks to months after recovery and may require later surgical repair, even in babies who never needed surgery initially.

Surgical NEC: GI Complications

Surgical NEC survivors face a range of potential GI complications:

Neurodevelopmental Outcomes

This is the outcome that surprises many families: NEC independently increases the risk of neurodevelopmental impairment beyond what would be expected from prematurity alone. Hintz et al. (PMID 15930226) followed 1,151 VLBW infants and found that NEC survivors had significantly higher rates of cerebral palsy, cognitive impairment, hearing loss, and vision problems compared to VLBW infants without NEC — even after controlling for gestational age. The mechanism likely involves the systemic inflammatory cascade of severe NEC injuring the developing brain during a critical window.

NEC survivors should be followed in dedicated NICU developmental follow-up programs (also called high-risk infant follow-up clinics) that track development through school age and connect families with early intervention services, physical therapy, occupational therapy, speech therapy, and special education resources as needed.

Grief, Trauma, and Support

For families whose babies do not survive NEC, grief is profound. NEC is the most common cause of death from gastrointestinal disease in neonates, and many NICU deaths follow periods of watchful waiting and hope before a final deterioration. Grief support through NICU social workers, bereavement programs, and peer support communities is essential.

Even when babies survive, NICU families commonly experience post-traumatic stress disorder (PTSD), anxiety, and depression. These are real, valid responses to a genuinely traumatic experience. Seek support — from your NICU social worker, your own medical providers, and from peer communities of families who have lived through NEC.

The NEC Society (necsociety.org) is a nonprofit advocacy and support organization founded by NEC survivors, parents who lost babies to NEC, and clinicians. It offers family support resources, research updates, and community connection. You are not alone.

Back to Table of Contents

Key Research Papers

  1. Neu J, Walker WA, 2011 — Necrotizing enterocolitis (N Engl J Med) — PMID: 21226498
  2. Lin PW, Stoll BJ, 2006 — Necrotizing enterocolitis (Lancet) — PMID: 16829300
  3. Quigley M, McGuire W, 2014 — Cochrane review: formula versus donor breast milk for feeding preterm or low birth weight infants — PMID: 25199919
  4. Alfaleh K et al., 2011 — Cochrane review: probiotics for prevention of necrotizing enterocolitis in preterm infants — PMID: 22161407
  5. Hintz SR et al., 2005 — Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis (Pediatrics) — PMID: 15930226
  6. Rees CM et al., 2007 — Surgical strategies for necrotizing enterocolitis: a systematic review (Arch Dis Child Fetal Neonatal Ed) — PMID: 17218381
  7. Gephart SM et al., 2012 — Changing the paradigm of defining, detecting, and diagnosing NEC: Bell's staging criteria — PMID: 22739563
  8. Blakely ML et al., 2006 — Laparotomy versus peritoneal drain for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants (Ann Surg) — PMID: 16772442
  9. Lucas A, Cole TJ, 1990 — Breast milk and neonatal necrotising enterocolitis (Lancet) — PMID: 1978356
  10. Sharma R et al., 2006 — Clinical correlates of necrotizing enterocolitis in critically ill preterm neonates with RBC transfusion — PMID: 16899787
  11. PubMed search: Bell staging criteria NEC systematic review
  12. Obladen M, 2009 — Necrotizing enterocolitis — 150 years of fruitless search for the cause (Neonatology) — PMID: 18836281

PubMed Topic Searches

  1. Necrotizing enterocolitis preterm infant prevention
  2. Necrotizing enterocolitis human breast milk donor
  3. Probiotics necrotizing enterocolitis randomized trial
  4. NEC surgery short bowel syndrome neonatal
  5. Necrotizing enterocolitis neurodevelopment outcome

Back to Table of Contents


Connections

Back to Table of Contents